Zoetis Option Alert: Jan, 2027 $175 Calls at the Bid: 8005 vs 8034 OI; Earnings 5/6 Before Open 

Zoetis Option Alert: Jan, 2027 $175 Calls at the Bid: 8005 @ $13.7 vs 8034 OI; Earnings 5/6 Before Open Ref=$146.09

Zoetis

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Bird flu, chickens, vet

Large Cap

News

Health Care

General

Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the impact of HPAI on poultry.

Zoetis Avian Influenza Vaccine Secures Conditional Approval In US For Use In Chickens

Wall Street

Equities

Macro Economic Events

Bonds

Broad U.S. Equity ETFs

Econ #s

Economics

ETFs

$BTC

CBRE

CROX

CSCO

SPDR Dow Jones Industrial Average ETF Trust

EQIX

GEHC

HUBS

INTC

LECO

PAYC

RDDT

Select Sector SPDR-Consumer Discretionary

ZBRA

Wall Street climbed on Thursday, even as the Producer Price Index (PPI) sharply exceeded estimates in January, reigniting concerns over persistent inflationary pressures. 

Stocks Rise Despite Hot Producer Inflation, Intel Soars, Bitcoin Drops Below $96,000: What&#39;s Driving Markets Thursday?

Space vs. Real-World Problems

Earnings

Guidance

Movers

Trading Ideas

Zoetis posted Q4 earnings above estimates with strong organic growth. 2025 guidance signals lower-than-expected revenue and EPS, sending shares down.

Zoetis Drops As 2025 Guidance Falls Short Of Estimates

Zoetis Inc

Ztest Electronics Inc

Press Releases

Zoetis to Participate in the Piper Sandler 36th Annual Healthcare Conference

Zoetis Declares First Quarter 2025 Dividend; Board Approves 16% Payment Increase

Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2024 Financial Results

Is Zoetis Inc. (NYSE: ZTS) Overvalued? Or Is It Worth Buying Now?

Zoetis Announces U.S. Label Update for Librela® (bedinvetmab injection), a Treatment to Control Canine Osteoarthritis (OA) Pain

Zoetis Declares Second Quarter 2025 Dividend

Zoetis Reports Fourth Quarter and Full Year 2024 Results

Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus

Zoetis to Participate in Upcoming Investor Conferences

Zoetis to Host Webcast and Conference Call on First Quarter 2025 Financial Results

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals

Axsome Therapeutics

AstraZeneca PLC - American Depositary Shares

AstraZeneca

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

HUTCHMED (China) Limited - American Depositary Shares

HUTCHMED (China)

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Johnson & Johnson

Eli Lilly

Merck & Co

Novo Nordisk

Novartis

Organon

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer

Pfizer

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Royalty Pharma plc - Class A Ordinary Shares

Royalty Pharma

Sanofi

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Comments

Zoetis

Unusual Options Activity for

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga